You know the potential of OTC switches and digital therapeutics. You also know the hurdles:
Juggling separate app devs, QMS tools, validation consultants, and retail integrators.
Navigating the maze of ACNU rules, SaMD validation (IEC 62304), and 21 CFR Part 11 is slowing you down.
Connecting digital screening to the point-of-sale feels like plumbing the impossible.
Audit trails, failure reporting, documentation – one slip means costly delays or worse.
AEGIS brings ACNU and SaMD execution into one platform — from pilot to post-market.
Build and deploy FDA-ready self-screening workflows with branching logic, EHR integration, and automated validation.
IEC 62304 and ISO 13485 compliant lifecycle support with version control and traceability for digital health submissions.
21 CFR Part 11 compliant records, automated ACNU failure reporting, and FDA-ready audit trails built-in.
Verification API for seamless POS and e-commerce integration. Connect eligibility to purchase instantly.
Monitor screening outcomes, success rates, and post-market safety signals with comprehensive dashboards.
Centralized CMS for educational content, digital labeling, and multi-product program management with version control.
Visual workflow builder with drag-and-drop nodes, EHR integration, and automated compliance checks. Create complex ACNU screening logic without writing code.

AEGIS delivers a patient-friendly screening experience that's compliant, secure, and conversion-optimized.

Patients see what to expect: simple questions, 3-minute completion, and privacy assurance.

EHR integration allows auto-fill from patient portals, or manual entry for flexibility.

Patients receive immediate eligibility results with next steps to purchase or consult.
AEGIS powers comprehensive patient engagement from initial screening through ongoing medication management and support.

FDA-compliant safety questionnaires in-app
Videos, safety info & digital labeling
Push notifications for adherence
One-tap re-ordering & subscriptions
HSA/FSA & insurance integration
Instant chat & telehealth access
AEGIS provides comprehensive patient support and flexible clinical study capabilities through configuration, with continuous platform evolution.
Comprehensive support infrastructure with embedded help and educational content throughout the screening experience.
Configuration-based study capabilities for pilot programs, actual-use studies, and clinical trials.
AEGIS continuously evolves to support advanced patient engagement and clinical trial workflows. Our roadmap includes:
AEGIS supports clinical studies through flexible configuration rather than dedicated in-app features. This approach allows sponsors to conduct pilot programs, actual-use studies, and label-comprehension trials using the same compliant infrastructure that powers commercial ACNU programs—without waiting for specialized study modules.
AEGIS eliminates the friction between digital development, regulatory affairs, and commercial teams.
Cut validation and integration time significantly. Go from pilot to launch faster.
Build on a foundation designed for FDA scrutiny from day one.
Replace multiple vendors with one integrated, compliant platform.
Let your experts concentrate on clinical strategy, not software infrastructure.

Manage all your drug programs, screening workflows, and compliance documentation from one unified dashboard.
AEGIS is engineered for the highest regulatory standards with comprehensive certifications and compliance frameworks.
Configurable screeners, automated failure reporting
IEC 62304 / ISO 13485 compliant lifecycle support
21 CFR Part 11 / Annex 11 compliant records & audit trails
SOC 2 Type II, ISO 27001, HIPAA-aligned infrastructure
10-year immutable record retention
MDSAP, GDPR, and international regulatory alignment





Get answers to common questions about AEGIS, ACNU, SaMD, and regulatory compliance.